Your browser doesn't support javascript.
loading
Radiation therapy for ventricular arrhythmias.
Liulu, Xingzhou; Balaji, Poornima; Barber, Jeffrey; De Silva, Kasun; Murray, Tiarne; Hickey, Andrew; Campbell, Timothy; Harris, Jill; Gee, Harriet; Ahern, Verity; Kumar, Saurabh; Hau, Eric; Qian, Pierre C.
Afiliação
  • Liulu X; Cardiology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Balaji P; Cardiology Department, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Barber J; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • De Silva K; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Murray T; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Hickey A; Cardiology Department, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Campbell T; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Harris J; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Gee H; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Ahern V; Cardiology Department, Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Kumar S; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Hau E; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Qian PC; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
Article em En | MEDLINE | ID: mdl-38698577
ABSTRACT
Ventricular arrhythmias (VA) can be life-threatening arrhythmias that result in significant morbidity and mortality. Catheter ablation (CA) is an invasive treatment modality that can be effective in the treatment of VA where medications fail. Recurrence occurs commonly following CA due to an inability to deliver lesions of adequate depth to cauterise the electrical circuits that drive VA or reach areas of scar responsible for VA. Stereotactic body radiotherapy is a non-invasive treatment modality that allows volumetric delivery of energy to treat circuits that cannot be reached by CA. It overcomes the weaknesses of CA and has been successfully utilised in small clinical trials to treat refractory VA. This article summarises the current evidence for this novel treatment modality and the steps that will be required to bring it to the forefront of VA treatment.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article